ResearcherFudan University Shanghai Cancer CenterNo recent work listed

Haiyong Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0124-5301; OpenAlex author ID A5101619550. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2016: 1 paper

Papers 1

Bufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signaling. Co-author DOI 10.3892/mmr.2016.5471 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zhouyu Ning · 1 shared paper, 2016 · strength 0.08
- Paper Bufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signaling. DOI 10.3892/mmr.2016.5471 ↗
Xiaoyan Zhu · 1 shared paper, 2016 · strength 0.08
- Paper Bufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signaling. DOI 10.3892/mmr.2016.5471 ↗
Zhiqiang Meng · 1 shared paper, 2016 · strength 0.08
- Paper Bufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signaling. DOI 10.3892/mmr.2016.5471 ↗
Ying-Yi Li · 1 shared paper, 2016 · strength 0.08
- Paper Bufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signaling. DOI 10.3892/mmr.2016.5471 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.